Alpha-6 beta-2 nicotinic acetylcholine receptor (α6β2* nAChR)

The alpha-6 beta-2 nicotinic acetylcholine receptor (α6β2* nAChR) is a specialized subtype of pentameric ligand-gated ion channels predominantly expressed in the dopaminergic neurons of the nigrostriatal and mesolimbic pathways (Gotti et al., 2010). The asterisk in its name indicates that these receptors often exist as complex heteromers, frequently incorporating additional subunits like beta-3 or alpha-4 to form functional channels (Quik et al., 2011). This receptor plays a pivotal role in the modulation of dopamine release in the striatum, which is essential for motor control and the processing of reward and reinforcement (UniProt P43681). Because of its restricted expression pattern, the α6β2* nAChR is a high-priority target for treating Parkinson's disease, as these receptors are selectively lost early in the disease progression (Yang et al., 2011). It is also heavily implicated in nicotine addiction, where it mediates the reinforcing effects of tobacco use (IUPHAR/BPS Guide to Pharmacology). Pharmacological intervention typically involves the use of selective agonists to compensate for dopaminergic deficits or antagonists to disrupt the reward cycle of addictive substances. However, the high structural similarity between nAChR subtypes poses a significant challenge for developing drugs that avoid off-target effects on the more widespread alpha-4 beta-2 or alpha-3 beta-4 receptors.

Other names

CHRNA6-CHRNB2 receptorAlpha6-containing nicotinic acetylcholine receptornAChR alpha6beta2 subtypeAlpha6beta2* nicotinic receptor

Agonist, partial agonist, or antagonist modulation of a pentameric ligand-gated cation channel to regulate presynaptic dopamine release in the striatum.